Cape Investment Advisory, Inc.
Position in ABCL — AbCellera Biologics Inc.
CIK 1944437
MCDONOUGH, GA
Position in ABCL
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,925
New position
Shares Held
500
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#143
of 150 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cape Investment Advisory, Inc. holds $406,155 across 34 Biotechnology names. ABCL ranks #16 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
2,430 | $94,794 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
181 | $89,907 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
3,709 | $81,078 | |
| 4 | MDXG |
Mimedx Group, Inc.
|
5,500 | $21,175 | |
| 5 | EXEL |
Exelixis, Inc.
|
313 | $17,030 | |
| 6 | ARGX |
Argenx SE
|
12 | $11,132 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
27 | $8,127 | |
| 8 | INSM |
INSMED Inc
|
69 | $7,356 |
All Filings in ABCL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,925 | 500 | Shares | Sole | 2026-07-23 | |
| No filing history on record for this holder in this stock. | ||||||